Cancer Care ProvidersNCT02730039
Meaning-Centered Psychotherapy Training for Cancer Care Providers
An observational study of Cancer Care Providers, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.
Trial summary
The purpose of this project, entitled "Meaning-Centered Psychotherapy Training for Cancer Care Providers," is to develop a multi-modal training program in Meaning-Centered Psychotherapy (MCP) for multidisciplinary cancer care clinicians who provide psycho-oncology and psychosocial palliative care services for cancer… Read more about this study
- Who is it for?
- Ages 21 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cancer Care Providers
- What is being tested?
- workshop, follow-up calls & webinars and assessments
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 350 participants
- Where
- 1 siteUnited States
- Study dates
- 11 Dec 2015to 11 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: clinicians (20% MSKCC providers \& 80% outside providers)
Who may be able to join
- Clinicians who provide psycho-oncology and/or psychosocial palliative care services for to patients with cancer and/or severe medical illness/disease at MSKCC, other institutions, or in the community, as per self-report.
- Completed online MCPT application form and commits to attend the two-day intensive MCPT program, complete training follow-up assessments, and participate in required follow-up training activities.
- Able to speak, read, and understand English proficiently to participate in MCPT training sessions and complete assessments.
Who cannot join
- Does not meet the criteria of an appropriate candidate for training program, as determined by review of the MCPT Application Evaluation Checklist in the opinion of the investigator.
- Materials for the training and the training will be conducted in English only.
Trial locations and contacts
1 site in 1 country.
United States1 site
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
About this study
The purpose of this project, entitled "Meaning-Centered Psychotherapy Training for Cancer Care Providers," is to develop a multi-modal training program in Meaning-Centered Psychotherapy (MCP) for multidisciplinary cancer care clinicians who provide psycho-oncology and psychosocial palliative care services for cancer patients.
- Conditions
- Cancer Care Providers
- Being tested
- workshop, follow-up calls & webinars, assessments
- Keywords
- Cancer Care Providers, Psychotherapy, 15-321
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
workshopBehavioural
follow-up calls & webinarsBehavioural
assessmentsBehavioural
| Study group | Role | What they receive |
|---|---|---|
| Cancer Care Providers | Provider will attend a MCPT two-day intensive workshop that will include:
* Didactic Components
* Experiential Exercises
* Simulated patient role plays with actors
* Provider completes MCPT Workshop Assessment MCPT POST-WORKSHOP IMPLEMTATION (OPTIONAL)
* MCP Core Competency Trainer rated Assessment
* MCP Pre \& Post Workshop Knowledge Assessment
* MCPT Session Evaluation Assessment Provider will participate in training follow-up calls \& webinars for approximately 6 -12 months following completion of MCPT workshop.
* Provider will have ongoing access to MCPT Website with a discussion board, training resources and materials for clinical care.
* Provider will complete follow-up assessment at 3, 6, 9, \& 12 months post-training
* Training Update
* Goal Evaluation Form
* MCP Core Competency Self-Assessment MCPT POST-WORKSHOP IMPLEMTATION (OPTIONAL) Receives: Behavioral: workshop; Behavioral: follow-up calls & webinars; Behavioral: assessments |
What is being measured
The primary outcome is the main question the study is designed to answer.
participant's skills uptake at the end of the MCPT session score range 0-10
Evaluation will take place on two levels, as data will be collected directly from: 1) MCPT participants and 2) MCP trainers. Data on the training will be collected before and during the MCPT session. Data on post-MCP training will be collected for one year following participation in the MCPT.
Measured: change from Baseline to 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Apr 2016 (estimated)
- Study start11 Dec 2015
- Primary completion11 Dec 2026 (estimated)
- Study completion11 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cancer Care ProvidersStudies of the same condition, open and under way.
- More trials run by Memorial Sloan Kettering Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 350 participants (actual)
Sponsor and investigators
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Sponsor type
- University, hospital or other
- Collaborators
- Stanford University, Northwestern University, MJHS Institute for Innovation in Palliative Care, Massachusetts General Hospital, City of Hope Medical Center, Dana-Farber Cancer Institute, New York Presbyterian Hospital, Odette Cancer Center - Sunnybrook Hospital, VA New York Harbor Healthcare System, University of Pennsylvania, Smilow Cancer Hospital - Yale New Haven Health, Department of Veterans Affairs, New Jersey, Vidant Cancer Care
- Responsible party
- Sponsor
- Investigators
- William Breitbart, MD, Principal investigator, Memorial Sloan Kettering Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02730039
- Sponsor's protocol ID
- 15-321
- Status last verified
- Jan 2025
- First submitted
- 15 Mar 2016
- Last updated
- 30 Dec 2025
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Meaning-Centered Psychotherapy Training for Cancer Care Providers
- ClinicalTrials.gov ID
- NCT02730039
- Acronym / sponsor ID
- 15-321
- Conditions
- Cancer Care Providers
- Keywords
- Cancer Care Providers, Psychotherapy, 15-321
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 350 participants (actual)
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterUniversity, hospital or other
- Collaborators
- Stanford University, Northwestern University, MJHS Institute for Innovation in Palliative Care, Massachusetts General Hospital, City of Hope Medical Center, Dana-Farber Cancer Institute, New York Presbyterian Hospital, Odette Cancer Center - Sunnybrook Hospital, VA New York Harbor Healthcare System, University of Pennsylvania, Smilow Cancer Hospital - Yale New Haven Health, Department of Veterans Affairs, New Jersey, Vidant Cancer Care
- Study start
- 11 Dec 2015 (actual)
- Primary completion
- 11 Dec 2026 (estimated)
- Study completion
- 11 Dec 2026 (estimated)
- First posted
- 6 Apr 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this project, entitled "Meaning-Centered Psychotherapy Training for Cancer Care Providers," is to develop a multi-modal training program in Meaning-Centered Psychotherapy (MCP) for multidisciplinary cancer care clinicians who provide psycho-oncology and psychosocial palliative care services for cancer patients.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Cancer Care Providers | – | Behavioral: workshop, Behavioral: follow-up calls & webinars, Behavioral: assessmentsProvider will attend a MCPT two-day intensive workshop that will include: * Didactic Components * Experiential Exercises * Simulated patient role plays with actors * Provider completes MCPT Workshop Assessment MCPT POST-WORKSHOP IMPLEMTATION (OPTIONAL) * MCP Core Competency Trainer rated Assessment * MCP Pre \& Post Workshop Knowledge Assessment * MCPT Session Evaluation Assessment Provider will participate in training follow-up calls \& webinars for approximately 6 -12 months following completion of MCPT workshop. * Provider will have ongoing access to MCPT Website with a discussion board, training resources and materials for clinical care. * Provider will complete follow-up assessment at 3, 6, 9, \& 12 months post-training * Training Update * Goal Evaluation Form * MCP Core Competency Self-Assessment MCPT POST-WORKSHOP IMPLEMTATION (OPTIONAL) |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- clinicians (20% MSKCC providers \& 80% outside providers)
Key inclusion criteria (3 listed)
- Clinicians who provide psycho-oncology and/or psychosocial palliative care services for to patients with cancer and/or severe medical illness/disease at MSKCC, other institutions, or in the community, as per self-report.
- Completed online MCPT application form and commits to attend the two-day intensive MCPT program, complete training follow-up assessments, and participate in required follow-up training activities.
- Able to speak, read, and understand English proficiently to participate in MCPT training sessions and complete assessments.
Key exclusion criteria (2 listed)
- Does not meet the criteria of an appropriate candidate for training program, as determined by review of the MCPT Application Evaluation Checklist in the opinion of the investigator.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| workshop | Behavioural | Cancer Care Providers |
| follow-up calls & webinars | Behavioural | Cancer Care Providers |
| assessments | Behavioural | Cancer Care Providers |
Primary outcome
participant's skills uptake at the end of the MCPT session score range 0-10
Time frame: change from Baseline to 12 months
Evaluation will take place on two levels, as data will be collected directly from: 1) MCPT participants and 2) MCP trainers. Data on the training will be collected before and during the MCPT session. Data on post-MCP training will be collected for one year following participation in the MCPT.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Dec 2025.
- Memorial Sloan Kettering Cancer CenterLink provided by the sponsor.
Related trials for Cancer Care Providers
Active, not recruiting
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
Breast Neoplasm, Colorectal Neoplasm
RecruitingObservational study
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
Cancer
Recruiting
Evaluating the Communication Between Patients and Providers in Cancer Clinics
Cancer
Recruiting
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
BRCA1 Mutation, POLD1 Gene Mutation
Active, not recruiting
Better Communication, Better Care Using SICG Assistant Based on Artificial Intelligence
Cancer Care Providers
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
William Breitbart, MD principal investigator
Memorial Sloan Kettering Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer Care Providers, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 30 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
participant's skills uptake at the end of the MCPT session score range 0-10 (time frame: change from Baseline to 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2025.